SCHEMBL2899262

SCHEMBL2899262

O=C(O)c1cnc2ccc(Nc3ccncc3)nn12

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 5/20 0.65
KCNH2 Q12809 4/20 0.45
FYN P06241 8/20 0.43
DYRK3 O43781 2/20 0.42
CCNT1 O60563 2/20 0.42
CCNA2 P20248 2/20 0.42
CDK2 P24941 2/20 0.42
CDK9 P50750 2/20 0.42
CDK5 Q00535 2/20 0.42
DYRK1A Q13627 2/20 0.42
CDK5R1 Q15078 2/20 0.42
DYRK2 Q92630 2/20 0.42
DYRK1B Q9Y463 2/20 0.42
TGFBR1 P36897 1/20 0.40
HCAR3 P49019 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2905619 0.85 KCNH2 (0.47) MKNK1KCNH2FYNDYRK3CCNT1
SCHEMBL2906009 0.82 FYN (0.51) MKNK1KCNH2FYNDYRK3CCNT1
SCHEMBL17437976 0.82 TYK2 (0.54) MKNK1KCNH2FYNDYRK3CCNT1
SCHEMBL3033429 0.79 MKNK1 (1.00) MKNK1KCNH2FYN
SCHEMBL3036704 0.79 MKNK1 (0.77) MKNK1KCNH2FYNDYRK3CCNT1
SCHEMBL1202745 0.77 MKNK1 (0.56) MKNK1KCNH2FYNDYRK3CCNT1
SCHEMBL21571847 0.77 TYK2 (0.49) MKNK1KCNH2FYNDYRK3CCNT1
SCHEMBL1202282 0.76 MKNK1 (0.49) MKNK1FYN
SCHEMBL3031885 0.76 MKNK1 (1.00) MKNK1KCNH2FYNDYRK3CCNT1
SCHEMBL1202742 0.74 MKNK1 (0.53) MKNK1FYNDYRK3CCNT1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217601-A1 IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) 2010-08-18 EP disclosed
WO-2009060197-A1 IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) 2009-05-14 WO disclosed